Pengembangan Sistem Nanostructured Lipid Carriers (NLC) Meloxicam dengan Lipid Monostearin dan Miglyol 808 Menggunakan Metode Emulsifikasi

Pengembangan Sistem Nanostructured Lipid Carriers (NLC) Meloxicam dengan Lipid Monostearin dan Miglyol 808 Menggunakan Metode Emulsifikasi

The aim this study was to determine the effect of Monostearin and Miglyol 808 lipid ratio in NLC system formulation resulting in physicochemical characteristics, release rate, and penetration rate. The NLC making was done by using emulsification method. In the formulation of NLC meloxicam, 3 differ...

Full description

Bibliographic Details
Main Authors:	Rahmi Annisa, Esti Hendradi, Dewi Melani
Format:	Article
Language:	English
Published:	Mulawarman University 2016-06-01
Series:	Journal of Tropical Pharmacy and Chemistry
Subjects:	NLC meloxicam physicochemical characterization release rate and penetration rate.
Online Access:	https://jtpc.farmasi.unmul.ac.id/index.php/jtpc/article/view/102

Similar Items

Effect of Lipid Ratio of Stearic Acid and Oleic Acid on Characteristics of Nanostructure Lipid Carrier (NLC) System of Diethylammonium Diclofenac
by: Esti Hendradi, et al.
Published: (2017-10-01)

Preparation and physicochemical characterization of meloxicam orally fast disintegration tablet using its solid dispersion
by: Zahra Shoormeij, et al.
Published: (2018-03-01)

Entrapment efficiency and drug loading of curcumin nanostructured lipid carrier (NLC) formula
by: Rabima Rabima, et al.
Published: (2019-11-01)

Moisturizing effects of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) using deionized and magnetized water by in vivo and in vitro methods
by: Susan Sarhadi, et al.
Published: (2020-03-01)

Physicochemical Characteristics, Stability, and Irritability of Nanostructured Lipid Carrier System Stabilized with Different Surfactant Ratios
by: Dyah Rahmasari, et al.
Published: (2022-04-01)

Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity
by: Raquel Vieira, et al.
Published: (2020-02-01)

Potential of Antioxidant-Loaded Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for the Management of Neurodegenerative Diseases
by: Joana Torres, et al.
Published: (2022-11-01)

Nanostructured Lipid Carriers (NLC)-Based Gel Formulations as Etodolac Delivery: From Gel Preparation to Permeation Study
by: Anna Czajkowska-Kośnik, et al.
Published: (2022-12-01)

INFLUENCE OF STABILIZERS IN MELOXICAM NANOCRYSTAL FORMATION AND ITS APPLICATION ON SUSPENSION ORAL DOSAGE FORM
by: Magdalena Yuni Kristanti, et al.
Published: (2013-10-01)

Investigation of Absorption Routes of Meloxicam and Its Salt Form from Intranasal Delivery Systems
by: Csilla Bartos, et al.
Published: (2018-03-01)

Preparation and Evaluation of Meloxicam Microsponges as Transdermal Delivery System
by: Roaa A. Nief, et al.
Published: (2017-02-01)

Meloxicam hydrochloride
by: Fermin Flores Manuel, et al.
Published: (2023-03-01)

How Charge, Size and Protein Corona Modulate the Specific Activity of Nanostructured Lipid Carriers (NLC) against <i>Helicobacter pylori</i>
by: Rute Chitas, et al.
Published: (2022-12-01)

Formulation and in vitro evaluation of meloxicam as a self-microemulsifying drug delivery system [version 2; peer review: 2 approved]
by: Khalid Kadhem Al-Kinani, et al.
Published: (2023-05-01)

An update on the application of nano-scaled carriers against fluconazole-resistant Candida species: nanostructured lipid carriers or solid lipid nanoparticles?
by: Maryam Moazeni, et al.
Published: (2019-12-01)

In Vitro Skin Permeation of Idebenone from Lipid Nanoparticles Containing Chemical Penetration Enhancers
by: Lucia Montenegro, et al.
Published: (2021-07-01)

Formulation Characterization and Evaluation of Meloxicam Nanoemulgel to be Used Topically
by: Hayder Kadhim Drais, et al.
Published: (2017-07-01)

Morphological and histopathological alterations caused by meloxicam in chick fetuses
by: Mervat AbdRabou, et al.
Published: (2022-11-01)

The effect of topical application of meloxicam on inflamed dental pulp
by: Jing-Yi Li, et al.
Published: (2021-07-01)

Screening for NOTCH2NLC gene dynamic mutation in patients with essential tremor
by: ZHANG Xinyi, ZHAO Ximeng, YANG Yingmai, WAN Xinhua, CUI Liying, ZHANG Xue, LIU Qing
Published: (2023-12-01)

Dissolution Kinetics of Meloxicam Formulations Co-Milled with Sodium Lauryl Sulfate
by: Jan Patera, et al.
Published: (2022-10-01)

The epidural analgesic effects of Meloxicam in dogs
by: Azin Tavakoli
Published: (2014-06-01)

Studying the Complex Formation of Sulfonatocalix[4]naphthalene and Meloxicam towards Enhancing Its Solubility and Dissolution Performance
by: Tayel A. Al Hujran, et al.
Published: (2021-06-01)

Development of a Nanostructured Lipid Carrier (NLC) by a Low-Energy Method, Comparison of Release Kinetics and Molecular Dynamics Simulation
by: Andrea C. Ortiz, et al.
Published: (2021-04-01)

Combination anesthetic therapy: co-delivery of ropivacaine and meloxicam using transcriptional transactivator peptide modified nanostructured lipid carriers in vitro and in vivo
by: Shu Yuan, et al.
Published: (2022-12-01)

Comparison the Efficacy of Meloxicam and Ketoprofen in Alleviating Pain Following Ovariectomy in Rats
by: Azin Tavakoli, et al.
Published: (2012-08-01)

Analgesia da farmacopuntura com meloxicam ou da aquapuntura preemptivas em gatas submetidas à ovariosalpingohisterectomia Analgesia of preemptive pharmacopuncture with meloxicam or aquapuncture in cats undergoing ovariohysterectomy
by: Nicole Ruas de Sousa, et al.
Published: (2012-07-01)

Use of meloxicam (amelotex®) in patients with gonarthrosis
by: Maksim Sergeevich Eliseev, et al.
Published: (2011-06-01)

Melox (meloxicam) clinical efficacy in chronic joint diseases
by: Sh Erdes, et al.
Published: (2003-08-01)

Meloxicam in the management of post-operative pain: Narrative review
by: Alex Bekker, et al.
Published: (2018-01-01)

Dissolution test optimization for meloxicam in the tablet pharmaceutical form
by: Érika de Fátima Silva Oliveira, et al.
Published: (2009-03-01)

Expression of expanded GGC repeats within NOTCH2NLC causes cardiac dysfunction in mouse models
by: Yongcheng Pan, et al.
Published: (2023-08-01)

Preliminary Investigation into a Novel Sustained-Release Formulation of Meloxicam in Sheep (<i>Ovis aries</i>)—Pharmacokinetic Profile
by: Christine Plummer, et al.
Published: (2021-08-01)

ANALYTICAL TECHNIQUES FOR THE DETERMINATION OF MELOXICAM IN PHARMACEUTICAL FORMULATIONS AND BIOLOGICAL SAMPLES
by: Aisha Noreen, et al.
Published: (2016-06-01)

Modulation of the pharmacological properties of meloxicam by octreotide in rats
by: Sally Abdul Wanees El-Awdan, et al.
Published: (2015-03-01)

Pengaruh Panjang Rantai Karbon Lipid Padat terhadap Karakteristik Nanostructured Lipid Carrier Resveratrol
by: Siti Aisiyah, et al.
Published: (2019-11-01)

Pharmacokinetic studies of meloxicam after its intravenous administration in local goat (Capra hircus) of Assam
by: Dulal C. Roy, et al.
Published: (2013-05-01)

Pharmacoeconomic analysis of the use of movalis (meloxicam) in patients with nonspecific back pain
by: O. N. Gerasimova, et al.
Published: (2011-12-01)

Tramadol Vs. Meloxicam in Controlling Postoperative Pain in Dental Extractions in Cats
by: Azin Tavakoli, et al.
Published: (2017-10-01)

Effects of meloxicam (Metacam®) on post-farrowing sow behaviour and piglet performance
by: E. Mainau, et al.
Published: (2012-01-01)